Search trends

Google broadens the site reputation abuse policy to any third-party content borrowing a host domain's signals

Google clarified that health websites can lose search rankings for hosting outside content meant to borrow the site's authority, but properly labeled affiliate links are still allowed [1].

By the Semaglutides news desk·

Google updated its site reputation abuse policy on November 19, 2024, making clear that publishing third-party pages on a site to exploit that site's search rankings is a violation, no matter how much the site owner is involved in producing or overseeing that content [1]. The change closes a gap some sites had used, such as white-label deals, licensing agreements, or partial ownership arrangements, to argue that outside content on their domain should not count as third-party [1].

Google's updated definition reads: "Site reputation abuse is the practice of publishing third-party pages on a site in an attempt to abuse search rankings by taking advantage of the host site's ranking signals" [1]. The company said its review of many cases showed that no amount of first-party involvement changes the fundamentally third-party nature of that content or removes the unfair advantage it gets from riding on an established site's reputation [1].

Google also spelled out what the policy does not cover. Third-party content by itself, including freelance writing, is not a violation unless it is also being used to exploit the host site's ranking signals [1]. Affiliate content is treated the same way: the policy is "not about targeting affiliate content," and affiliate links that are marked appropriately, for example with proper disclosure tags, are not considered site reputation abuse [1]. Sites found in violation receive a manual action notice through Google Search Console and can file a reconsideration request [1].

The update also addresses what happens if a site tries to fix a violation. Simply adding a noindex tag to the offending content does not automatically remove a manual action; site owners still must reply in Search Console [1]. Moving flagged content to a subdirectory or subdomain on the same domain does not resolve the issue and may be treated as an attempt to get around the policy, which Google said "may lead to broader actions against a site" [1]. Moving the content to a brand-new domain with no established reputation is far less likely to trigger a problem, as long as the site follows Google's other spam policies [1].

Why it matters for patients

Many people researching GLP-1 medications such as semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), or orforglipron (Foundayo) start with a Google search. This policy update affects which kinds of health websites show up in those results. Sites that host outsourced or licensed content simply to borrow the ranking power of an established domain can now be penalized for that practice, even if the site's own staff reviewed the material [1]. That is meant to reduce lower-quality or non-independent content in search results.

At the same time, the clarification confirms that affiliate-supported health sites are not automatically penalized just for having affiliate links [1]. A site that discloses its affiliate relationships properly can still carry that content without violating the policy [1]. For readers, this means the presence of affiliate links on a health site is not, by itself, a sign that Google considers the site low quality or manipulative. It also means search rankings for medication information could shift over time as Google enforces this clarified standard, though the sources here do not describe specific effects on any named drug information sites.

What happens next

Google said the clarified policy took effect on November 19, 2024, and encouraged site owners to review it and focus on content built for readers rather than for ranking purposes [1]. The sources do not specify a timeline for enforcement actions or provide data on how many sites have received manual actions under the updated language.

Sources

  1. https://developers.google.com/search/blog/2024/11/site-reputation-abuse

Semaglutides.org is for information only and is not medical advice. Always talk to a licensed healthcare provider about your own care. Some links to telehealth services are affiliate links, labeled where they appear.